Inhaltsbereich
| 99 Einträge | 1, 2, 3, 4, 5 › » |
Seite 1 / 5
 Druckansicht
|
| Variations in genes involved in dormancy associated with outcome in patients with resected colorectal liver metastases. |
| Stremitzer S, Zhang W, Yang D, Ning Y, Stintzing S, Sunakawa Y, Sebio A, Yamauchi S, Matsusaka S, Parekh A, Barzi A, El-Khoueiry R, Stift J, Wrba F, Gruenberger T, Lenz HJ |
| Annals of oncology : official journal of the European Society for Medical Oncology / ESMO. 2015 May 8. pii: mdv224. doi: 10.1093/annonc/mdv224. pmc: PMC4511220 |
| PMID: 25957329 |
| Histological response, pattern of tumor destruction and clinical outcome after neoadjuvant chemotherapy including bevacizumab or cetuximab in patients undergoing liver resection for colorectal liver metastases. |
| Stremitzer S, Stift J, Singh J, Starlinger P, Gruenberger B, Tamandl D, Gruenberger T |
| European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 2015 Mar 24. pii: S0748-7983(15)00335-2. doi: 10.1016/j.ejso.2015.03.223 |
| PMID: 25865557 |
| Variations in genes involved in immune response checkpoints and association with outcomes in patients with resected colorectal liver metastases. |
| Stremitzer S, Sunakawa Y, Zhang W, Yang D, Ning Y, Stintzing S, Sebio A, Yamauchi S, Matsusaka S, El-Khoueiry R, Stift J, Wrba F, Gruenberger T, Lenz HJ |
| The pharmacogenomics journal. 2015 Mar 10. pii: tpj201514. doi: 10.1038/tpj.2015.14 |
| PMID: 25752522 |
| Genetic variations in angiopoietin and pericyte pathways and clinical outcome in patients with resected colorectal liver metastases. |
| Stremitzer S, Zhang W, Yang D, Ning Y, Stintzing S, Sebio A, Sunakawa Y, Yamauchi S, Matsusaka S, El-Khoueiry R, Stift J, Wrba F, Gruenberger T, Lenz HJ |
| Cancer. 2015 Feb 17. doi: 10.1002/cncr.29259. pmc: PMC4441595. mid: NIHMS654331 |
| PMID: 25690670 |
| Bevacizumab plus mFOLFOX-6 or FOLFOXIRI in patients with initially unresectable liver metastases from colorectal cancer: the OLIVIA multinational randomised phase II trial. |
| Gruenberger T, Bridgewater J, Chau I, García Alfonso P, Rivoire M, Mudan S, Lasserre S, Hermann F, Waterkamp D, Adam R |
| Annals of oncology : official journal of the European Society for Medical Oncology / ESMO. 2014 Dec 23. pii: mdu580. doi: 10.1093/annonc/mdu580 |
| PMID: 25538173 |
| Multicenter analysis of soluble Axl reveals diagnostic value for very early stage hepatocellular carcinoma. |
| Reichl P, Fang M, Starlinger P, Staufer K, Nenutil R, Muller P, Greplova K, Valik D, Dooley S, Brostjan C, Gruenberger T, Shen J, Man K, Trauner M, Yu J, Gao CF, Mikulits W |
| International journal of cancer. Journal international du cancer. 2015 Jan 13. doi: 10.1002/ijc.29394. pmc: PMC4450342. mid: EMS63560 |
| PMID: 25529751 |
| CEA change after neoadjuvant chemotherapy including bevacizumab and clinical outcome in patients undergoing liver resection for colorectal liver metastases. |
| Stremitzer S, Stift J, Graf A, Singh J, Starlinger P, Gruenberger B, Tamandl D, Gruenberger T |
| Annals of surgical oncology. 2014 Oct 17. doi: 10.1245/s10434-014-4158-8 |
| PMID: 25323471 |
| Local recurrence rates after radiofrequency ablation or resection of colorectal liver metastases. Analysis of the European Organisation for Research and Treatment of Cancer #40004 and #40983. |
| Tanis E, Nordlinger B, Mauer M, Sorbye H, van Coevorden F, Gruenberger T, Schlag PM, Punt CJ, Ledermann J, Ruers TJ |
| European journal of cancer (Oxford, England : 1990). 2014 Jan 7. pii: S0959-8049(13)01102-7. doi: 10.1016/j.ejca.2013.12.008 |
| PMID: 24411080 |
| Intermediate monocytes but not TIE2-expressing monocytes are a sensitive diagnostic indicator for colorectal cancer. |
| Schauer D, Starlinger P, Reiter C, Jahn N, Zajc P, Buchberger E, Bachleitner-Hofmann T, Bergmann M, Stift A, Gruenberger T, Brostjan C |
| PloS one. 2012 Sep 4. doi: 10.1371/journal.pone.0044450. pii: PONE-D-12-05747. pmc: PMC3433422 |
| PMID: 22973451 |
| Pathologic response to bevacizumab-containing chemotherapy in patients with colorectal liver metastases and its correlation with survival. |
| Gruenberger T, Arnold D, Rubbia-Brandt L |
| Surgical oncology. 2012 Aug 9. pii: S0960-7404(12)00056-4. doi: 10.1016/j.suronc.2012.07.003 |
| PMID: 22884035 |
| Neoadjuvant bevacizumab persistently inactivates VEGF at the time of surgery despite preoperative cessation. |
| Starlinger P, Alidzanovic L, Schauer D, Maier T, Nemeth C, Perisanidis B, Tamandl D, Gruenberger B, Gruenberger T, Brostjan C |
| British journal of cancer. 2012 Jul 31. pii: bjc2012342. doi: 10.1038/bjc.2012.342. pmc: PMC3464762 |
| PMID: 22850548 |
| Gadoxetic acid-enhanced 3.0 T MR imaging versus multidetector-row CT in the detection of colorectal metastases in fatty liver using intraoperative ultrasound and histopathology as a standard of reference. |
| Berger-Kulemann V, Schima W, Baroud S, Koelblinger C, Kaczirek K, Gruenberger T, Schindl M, Maresch J, Weber M, Ba-Ssalamah A |
| European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 2012 May 30. pii: S0748-7983(12)00311-3. doi: 10.1016/j.ejso.2012.05.004 |
| PMID: 22652037 |
| Value of hepatic venous pressure gradient measurement before liver resection for hepatocellular carcinoma. |
| Stremitzer S, Tamandl D, Kaczirek K, Maresch J, Abbasov B, Payer BA, Ferlitsch A, Gruenberger T |
| The British journal of surgery. 2011 Oct 19. doi: 10.1002/bjs.7672 |
| PMID: 22009385 |
| Evaluation of chemotherapy-associated liver injury in patients with colorectal cancer liver metastases using indocyanine green clearance testing. |
| Krieger PM, Tamandl D, Herberger B, Faybik P, Fleischmann E, Maresch J, Gruenberger T |
| Annals of surgical oncology. 2011 Jan 5. doi: 10.1245/s10434-010-1494-1 |
| PMID: 21207168 |
| Sinusoidal obstruction syndrome impairs long-term outcome of colorectal liver metastases treated with resection after neoadjuvant chemotherapy. |
| Tamandl D, Klinger M, Eipeldauer S, Herberger B, Kaczirek K, Gruenberger B, Gruenberger T |
| Annals of surgical oncology. 2010 Sep 16. doi: 10.1245/s10434-010-1317-4 |
| PMID: 20844968 |
| Liver resection remains a safe procedure after neoadjuvant chemotherapy including bevacizumab: a case-controlled study. |
| Tamandl D, Gruenberger B, Klinger M, Herberger B, Kaczirek K, Fleischmann E, Gruenberger T |
| Annals of surgery. 2010 Jun 23. doi: 10.1097/SLA.0b013e3181deb67f |
| PMID: 20562613 |
| Preoperative detection of colorectal liver metastases in fatty liver: MDCT or MRI? |
| Kulemann V, Schima W, Tamandl D, Kaczirek K, Gruenberger T, Wrba F, Weber M, Ba-Ssalamah A |
| European journal of radiology. 2010 Apr 13. pii: S0720-048X(10)00103-8. doi: 10.1016/j.ejrad.2010.03.004 |
| PMID: 20392584 |
| Bevacizumab improves pathological response of colorectal cancer liver metastases treated with XELOX/FOLFOX. |
| Klinger M, Tamandl D, Eipeldauer S, Hacker S, Herberger B, Kaczirek K, Dorfmeister M, Gruenberger B, Gruenberger T |
| Annals of surgical oncology. 2010 Feb 23. doi: 10.1245/s10434-010-0972-9 |
| PMID: 20177795 |
| The EGF 61A/G polymorphism - a predictive marker for recurrence of liver metastases from colorectal cancer. |
| Kovar FM, Thallinger C, Marsik CL, Perkmann T, Puhalla H, Haslacher H, Wrba F, Wagner OF, Gruenberger T, Endler G |
| Wiener klinische Wochenschrift. 2009 Nov 20. doi: 10.1007/s00508-009-1250-3 |
| PMID: 19921131 |
| Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study. |
| Lammer J, Malagari K, Vogl T, Pilleul F, Denys A, Watkinson A, Pitton M, Sergent G, Pfammatter T, Terraz S, Benhamou Y, Avajon Y, Gruenberger T, Pomoni M, Langenberger H, Schuchmann M, Dumortier J, Mueller C, Chevallier P, Lencioni R |
| Cardiovascular and interventional radiology. 2009 Nov 12. doi: 10.1007/s00270-009-9711-7. pmc: PMC2816794 |
| PMID: 19908093 |
| 99 Einträge | 1, 2, 3, 4, 5 › » |
Seite 1 / 5
Druckansicht
|
Schnellinfo
-- Initiative Krebsforschung / Krebsforschungslauf
-- Cancer Care
-- Kliniken und Partner
-- CCC Cancer School
-- Young CCC
-- CCC Tumorboards
-- CCC Forschungscluster
-- CCC Units
-- CCC Platforms
-- SOPs / Leitlinien
-- Kontakt
-- Cancer Care
-- Kliniken und Partner
-- CCC Cancer School
-- Young CCC
-- CCC Tumorboards
-- CCC Forschungscluster
-- CCC Units
-- CCC Platforms
-- SOPs / Leitlinien
-- Kontakt
Featured
